Synonyms: | |
Status: | Phase 3 |
Entry Type: | Small molecule |
Molecule Category: | UNKNOWN |
UNII: | W980KJ009P |
InChI Key | OMFXVFTZEKFJBZ-HJTSIMOOSA-N |
---|---|
Smile | |
InChI |
|
Property Name | Value |
---|---|
Molecular Formula | C21H30O4 |
Molecular Weight | 346.47 |
AlogP | 2.67 |
Hydrogen Bond Acceptor | 4.0 |
Hydrogen Bond Donor | 2.0 |
Number of Rotational Bond | 2.0 |
Polar Surface Area | 74.6 |
Molecular species | NEUTRAL |
Aromatic Rings | 0.0 |
Heavy Atoms | 25.0 |
Primary Target | |
---|---|
Glucocorticoid receptor |
Targets | EC50(nM) | IC50(nM) | Kd(nM) | Ki(nM) | Inhibition(%) | |
---|---|---|---|---|---|---|
Enzyme
Oxidoreductase
|
- | - | - | - | 8-15 | |
Membrane receptor
|
- | - | - | 35600 | - | |
Secreted protein
|
- | - | 457 | 13-63 | - | |
Transcription factor
Nuclear receptor
Nuclear hormone receptor subfamily 3
Nuclear hormone receptor subfamily 3 group C
Nuclear hormone receptor subfamily 3 group C member 2
|
- | - | 1 | - | - | |
Transcription factor
Nuclear receptor
Nuclear hormone receptor subfamily 3
Nuclear hormone receptor subfamily 3 group C
Nuclear hormone receptor subfamily 3 group C member 4
|
- | 23442 | - | - | - | |
Transporter
Electrochemical transporter
SLC superfamily of solute carriers
SLC22 family of organic cation and anion transporters
|
- | - | - | - | 34 |
Mesh Heading | Maximum Phase | Mesh ID | Reference |
---|---|---|---|
Osteoarthritis, Hip | 3 | D015207 | ClinicalTrials |
Resources | Reference |
---|---|
CAS NUMBER | 50-22-6 |
ChEBI | 16827 |
ChEMBL | CHEMBL110739 |
DrugBank | DB04652 |
EPA CompTox | DTXSID6022474 |
FDA SRS | W980KJ009P |
Human Metabolome Database | HMDB0001547 |
Guide to Pharmacology | 2869 |
KEGG | C02140 |
PDB | C0R |
PubChem | 5753 |
SureChEMBL | SCHEMBL22612 |
ZINC | ZINC000013513592 |